Naomi Meeks
Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intellectual Disability | 8 | 2024 | 153 | 1.040 |
Why?
| Dwarfism | 1 | 2023 | 15 | 0.860 |
Why?
| Osteochondrodysplasias | 1 | 2023 | 15 | 0.850 |
Why?
| Pseudohypoparathyroidism | 1 | 2022 | 3 | 0.790 |
Why?
| Cardiomyopathies | 1 | 2022 | 333 | 0.590 |
Why?
| Hypopituitarism | 1 | 2015 | 15 | 0.480 |
Why?
| Craniofacial Abnormalities | 3 | 2021 | 62 | 0.470 |
Why?
| Cystinuria | 2 | 2024 | 4 | 0.450 |
Why?
| Neurodevelopmental Disorders | 3 | 2022 | 153 | 0.450 |
Why?
| Autism Spectrum Disorder | 4 | 2020 | 375 | 0.440 |
Why?
| Developmental Disabilities | 5 | 2021 | 254 | 0.430 |
Why?
| Seizures | 3 | 2021 | 395 | 0.360 |
Why?
| Genetic Testing | 3 | 2024 | 425 | 0.300 |
Why?
| Adrenal Insufficiency | 2 | 2021 | 31 | 0.290 |
Why?
| Phenotype | 8 | 2022 | 3062 | 0.280 |
Why?
| Amino Acid Transport Systems, Basic | 2 | 2024 | 4 | 0.280 |
Why?
| Cystine | 2 | 2024 | 16 | 0.280 |
Why?
| Mutation, Missense | 2 | 2018 | 319 | 0.250 |
Why?
| Dichloroacetic Acid | 1 | 2024 | 8 | 0.240 |
Why?
| Acidosis, Lactic | 1 | 2024 | 44 | 0.230 |
Why?
| Heterozygote | 1 | 2024 | 269 | 0.220 |
Why?
| Glypicans | 1 | 2023 | 9 | 0.220 |
Why?
| Child, Preschool | 11 | 2024 | 10462 | 0.210 |
Why?
| Aggression | 1 | 2024 | 196 | 0.200 |
Why?
| Nervous System Malformations | 1 | 2022 | 35 | 0.200 |
Why?
| Face | 2 | 2022 | 168 | 0.200 |
Why?
| Chromogranins | 1 | 2022 | 12 | 0.200 |
Why?
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2022 | 8 | 0.200 |
Why?
| Siblings | 1 | 2023 | 220 | 0.200 |
Why?
| Autistic Disorder | 1 | 2024 | 184 | 0.190 |
Why?
| Hedgehog Proteins | 1 | 2023 | 187 | 0.190 |
Why?
| Research Report | 1 | 2022 | 76 | 0.190 |
Why?
| Channelopathies | 1 | 2011 | 5 | 0.190 |
Why?
| Segmental Duplications, Genomic | 1 | 2021 | 7 | 0.180 |
Why?
| Genomic Structural Variation | 1 | 2021 | 12 | 0.180 |
Why?
| Williams Syndrome | 1 | 2021 | 13 | 0.180 |
Why?
| Neurotransmitter Agents | 1 | 2011 | 82 | 0.180 |
Why?
| Chromosome Disorders | 1 | 2021 | 39 | 0.180 |
Why?
| Congenital Disorders of Glycosylation | 1 | 2020 | 9 | 0.180 |
Why?
| Adrenal Hyperplasia, Congenital | 1 | 2021 | 36 | 0.170 |
Why?
| N-Acetylglucosaminyltransferases | 1 | 2020 | 22 | 0.170 |
Why?
| Mutation | 7 | 2023 | 3679 | 0.170 |
Why?
| Genetic Predisposition to Disease | 2 | 2021 | 2273 | 0.170 |
Why?
| Neurogenesis | 1 | 2011 | 118 | 0.170 |
Why?
| Evidence-Based Medicine | 1 | 2024 | 731 | 0.170 |
Why?
| Facies | 1 | 2019 | 21 | 0.160 |
Why?
| Humans | 27 | 2024 | 129078 | 0.160 |
Why?
| Spasms, Infantile | 1 | 2020 | 118 | 0.150 |
Why?
| Aldehyde Dehydrogenase | 1 | 2019 | 103 | 0.150 |
Why?
| cdc42 GTP-Binding Protein | 1 | 2018 | 23 | 0.150 |
Why?
| Chromosomes, Human, Pair 15 | 3 | 2021 | 55 | 0.140 |
Why?
| Noonan Syndrome | 1 | 2018 | 17 | 0.140 |
Why?
| Genetic Heterogeneity | 1 | 2018 | 55 | 0.140 |
Why?
| RNA Helicases | 1 | 2017 | 24 | 0.140 |
Why?
| Farber Lipogranulomatosis | 1 | 2017 | 4 | 0.140 |
Why?
| Muscular Atrophy | 1 | 2018 | 79 | 0.140 |
Why?
| Conjunctival Diseases | 1 | 2017 | 18 | 0.140 |
Why?
| Child | 10 | 2024 | 20860 | 0.140 |
Why?
| Synovitis | 1 | 2017 | 27 | 0.140 |
Why?
| Premature Birth | 1 | 2020 | 313 | 0.130 |
Why?
| Imaging, Three-Dimensional | 1 | 2020 | 559 | 0.130 |
Why?
| Prader-Willi Syndrome | 1 | 2016 | 27 | 0.130 |
Why?
| Abnormalities, Multiple | 1 | 2018 | 178 | 0.130 |
Why?
| Arthritis | 1 | 2017 | 114 | 0.130 |
Why?
| Uveitis | 1 | 2017 | 128 | 0.130 |
Why?
| Energy Metabolism | 1 | 2011 | 837 | 0.120 |
Why?
| Holoprosencephaly | 1 | 2015 | 8 | 0.120 |
Why?
| Diabetes Insipidus | 1 | 2015 | 7 | 0.120 |
Why?
| Adolescent | 7 | 2024 | 20241 | 0.120 |
Why?
| Male | 17 | 2024 | 63248 | 0.120 |
Why?
| Epilepsy | 1 | 2019 | 315 | 0.120 |
Why?
| Human Growth Hormone | 1 | 2015 | 44 | 0.120 |
Why?
| Thyrotropin | 1 | 2015 | 109 | 0.120 |
Why?
| Hypogonadism | 1 | 2015 | 82 | 0.120 |
Why?
| Heart Defects, Congenital | 1 | 2021 | 752 | 0.110 |
Why?
| Transcription Factors | 1 | 2021 | 1636 | 0.110 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 485 | 0.090 |
Why?
| Infant | 7 | 2020 | 8997 | 0.090 |
Why?
| Female | 13 | 2024 | 68274 | 0.090 |
Why?
| Mosaicism | 1 | 2011 | 71 | 0.090 |
Why?
| Sequence Deletion | 1 | 2011 | 180 | 0.090 |
Why?
| Proteins | 1 | 2016 | 945 | 0.090 |
Why?
| Frameshift Mutation | 1 | 2010 | 32 | 0.090 |
Why?
| Exons | 1 | 2011 | 332 | 0.080 |
Why?
| Brain | 1 | 2011 | 2604 | 0.080 |
Why?
| Chromosome Mapping | 3 | 2022 | 505 | 0.080 |
Why?
| HEK293 Cells | 2 | 2024 | 674 | 0.080 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2010 | 156 | 0.080 |
Why?
| Syndrome | 3 | 2020 | 343 | 0.080 |
Why?
| Tandem Repeat Sequences | 1 | 2006 | 18 | 0.070 |
Why?
| Repressor Proteins | 1 | 2010 | 400 | 0.070 |
Why?
| Infertility, Male | 1 | 2006 | 61 | 0.070 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2006 | 113 | 0.070 |
Why?
| Autoimmune Diseases | 1 | 2010 | 421 | 0.060 |
Why?
| Hearing Loss, Sensorineural | 1 | 2006 | 56 | 0.060 |
Why?
| Infant, Newborn | 3 | 2024 | 5707 | 0.060 |
Why?
| Gene Deletion | 1 | 2006 | 375 | 0.060 |
Why?
| Pyruvate Dehydrogenase (Lipoamide) | 1 | 2024 | 10 | 0.060 |
Why?
| Amino Acid Transport Systems, Neutral | 1 | 2024 | 4 | 0.060 |
Why?
| PDZ Domains | 1 | 2024 | 4 | 0.060 |
Why?
| Amino Acid Transport System y+ | 1 | 2024 | 8 | 0.060 |
Why?
| Genotype | 2 | 2020 | 1835 | 0.060 |
Why?
| Incidental Findings | 1 | 2024 | 80 | 0.050 |
Why?
| Introns | 1 | 2024 | 242 | 0.050 |
Why?
| Whole Genome Sequencing | 1 | 2024 | 131 | 0.050 |
Why?
| Histone Demethylases | 1 | 2022 | 31 | 0.050 |
Why?
| Genetics, Population | 1 | 2023 | 200 | 0.050 |
Why?
| Gene Frequency | 1 | 2023 | 503 | 0.050 |
Why?
| Membrane Proteins | 2 | 2024 | 1102 | 0.050 |
Why?
| Hypertelorism | 1 | 2021 | 1 | 0.050 |
Why?
| Gene Expression | 2 | 2018 | 1477 | 0.050 |
Why?
| Muscle Hypotonia | 1 | 2021 | 32 | 0.050 |
Why?
| Adult | 5 | 2024 | 35423 | 0.050 |
Why?
| Chromosome Breakpoints | 1 | 2021 | 6 | 0.050 |
Why?
| Chromosomes, Human, Pair 16 | 1 | 2021 | 31 | 0.050 |
Why?
| Genes, X-Linked | 1 | 2020 | 18 | 0.040 |
Why?
| Synapses | 1 | 2024 | 385 | 0.040 |
Why?
| Chromosome Deletion | 1 | 2021 | 104 | 0.040 |
Why?
| Nerve Tissue Proteins | 1 | 2024 | 570 | 0.040 |
Why?
| Transferrin | 1 | 2020 | 42 | 0.040 |
Why?
| Diet, Ketogenic | 1 | 2020 | 34 | 0.040 |
Why?
| Glycosylation | 1 | 2020 | 144 | 0.040 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 2020 | 111 | 0.040 |
Why?
| 2-Aminoadipic Acid | 1 | 2019 | 8 | 0.040 |
Why?
| Young Adult | 3 | 2024 | 12310 | 0.040 |
Why?
| Critical Illness | 1 | 2024 | 758 | 0.040 |
Why?
| Phosphoproteins | 1 | 2021 | 326 | 0.040 |
Why?
| Consanguinity | 2 | 2010 | 47 | 0.040 |
Why?
| Proteomics | 1 | 2024 | 988 | 0.040 |
Why?
| Nuclear Proteins | 1 | 2022 | 644 | 0.040 |
Why?
| Prevalence | 1 | 2024 | 2541 | 0.040 |
Why?
| Fluorometholone | 1 | 2017 | 4 | 0.040 |
Why?
| Pedigree | 2 | 2010 | 491 | 0.030 |
Why?
| Nod2 Signaling Adaptor Protein | 1 | 2017 | 33 | 0.030 |
Why?
| Protein Structure, Secondary | 1 | 2018 | 335 | 0.030 |
Why?
| Diagnosis, Differential | 1 | 2011 | 1435 | 0.030 |
Why?
| Adenosine Triphosphatases | 1 | 2017 | 164 | 0.030 |
Why?
| Genomic Imprinting | 1 | 2016 | 33 | 0.030 |
Why?
| Genetic Variation | 1 | 2021 | 935 | 0.030 |
Why?
| Neurons | 1 | 2024 | 1437 | 0.030 |
Why?
| Central Nervous System | 1 | 2017 | 254 | 0.030 |
Why?
| Sarcoidosis | 1 | 2017 | 151 | 0.030 |
Why?
| Base Sequence | 2 | 2010 | 2157 | 0.030 |
Why?
| Child Development | 1 | 2019 | 451 | 0.030 |
Why?
| Amino Acids | 1 | 2017 | 470 | 0.030 |
Why?
| Molecular Sequence Data | 2 | 2010 | 2846 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2022 | 2523 | 0.030 |
Why?
| DNA-Binding Proteins | 1 | 2020 | 1424 | 0.030 |
Why?
| Models, Molecular | 1 | 2018 | 1480 | 0.030 |
Why?
| Glucocorticoids | 1 | 2017 | 571 | 0.030 |
Why?
| Cognition | 1 | 2020 | 1097 | 0.030 |
Why?
| Mental Disorders | 1 | 2021 | 1026 | 0.020 |
Why?
| Cell Line | 1 | 2017 | 2762 | 0.020 |
Why?
| Gene Order | 1 | 2011 | 26 | 0.020 |
Why?
| RNA | 1 | 2017 | 877 | 0.020 |
Why?
| Chromosomes, Human, X | 1 | 2011 | 72 | 0.020 |
Why?
| Chromosomes, Human, Pair 20 | 1 | 2010 | 16 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2017 | 3114 | 0.020 |
Why?
| Mutagenesis, Insertional | 1 | 2010 | 66 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2018 | 2768 | 0.020 |
Why?
| Homozygote | 1 | 2010 | 192 | 0.020 |
Why?
| Age of Onset | 1 | 2011 | 494 | 0.020 |
Why?
| Biomarkers | 1 | 2020 | 3878 | 0.020 |
Why?
| Phosphotransferases (Phosphate Group Acceptor) | 1 | 2006 | 1 | 0.020 |
Why?
| Seminal Plasma Proteins | 1 | 2006 | 10 | 0.020 |
Why?
| Pseudogenes | 1 | 2006 | 18 | 0.020 |
Why?
| Chromosome Breakage | 1 | 2006 | 21 | 0.020 |
Why?
| Iran | 1 | 2006 | 38 | 0.020 |
Why?
| Sperm Motility | 1 | 2006 | 30 | 0.020 |
Why?
| Creatine Kinase | 1 | 2006 | 77 | 0.020 |
Why?
| Genes, Recessive | 1 | 2006 | 75 | 0.020 |
Why?
| Ion Channels | 1 | 2006 | 126 | 0.020 |
Why?
| Sequence Alignment | 1 | 2006 | 333 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 2010 | 2050 | 0.020 |
Why?
| Calcium Channels | 1 | 2006 | 149 | 0.020 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2006 | 155 | 0.020 |
Why?
| Haplotypes | 1 | 2006 | 473 | 0.010 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2006 | 376 | 0.010 |
Why?
| Nucleic Acid Conformation | 1 | 2006 | 705 | 0.010 |
Why?
| DNA | 1 | 2010 | 1407 | 0.010 |
Why?
| Animals | 1 | 2024 | 34708 | 0.010 |
Why?
| United States | 1 | 2010 | 13992 | 0.010 |
Why?
|
|
Meeks's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|